Evidence map›Paper›PMID 34030486›Full record

ArticleLGBT health2021

Anal Cancer Screening for HIV-Negative Men Who Have Sex with Men: Making Clinical Decisions with Limited Data.

Michael A Fuchs, Ami G Multani, Kenneth H Mayer, Alex S Keuroghlian

Abstract read
In one paragraph

Article in LGBT health, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Michael A FuchsDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Ami G MultaniDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Kenneth H MayerDepartment of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
Alex S KeuroghlianDepartment of Psychiatry, Harvard Medical School, Boston, Massachusetts, USA.ORCID 0000-0002-6624-8354

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Anal cancer is a rare disease that disproportionately affects people living with HIV and men who have sex with men (MSM). Although screening of MSM living with HIV occurs in the absence of consistent national guidelines, less research exists on screening HIV-negative MSM. In this article, we discuss patient-, clinician-, and systems-level factors that may influence decisions to screen HIV-negative MSM. Randomized controlled trials with MSM living with HIV and those at high risk are in progress, yet more research is needed to address clinical uncertainty around screening additional at-risk groups.

Indexed as

Clinical Decision-MakingEarly Detection of CancerAnus NeoplasmsHIV InfectionsHomosexuality, MaleHumansMaleanal cancerHIVhuman papillomavirus (HPV)men who have sex with men (MSM)preventionscreening

Identifiers

PMID34030486
PMCPMC8252895

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.